Skip to content
Frenxiv is the French preprint archive for all scientific fields, operating on the Open Science Framework. About the archive
Frenxiv archive mark FrenxivFrench preprint archive

Preprint record

Euglycemic diabetic ketoacidosis in type 2 diabetes mellitus treated with SGLT2 inhibitors a report on two cases

Antonio Burgio, Maurizio Alletto, Salvatore Amico, Umberto Castiglione, Giovanni Fulco, Concetta Groppuso and Gianfranco Gruttadauria

Published February 24, 2019 DOI 10.31226/osf.io/sphax Publisher Frenxiv Type Preprint

Abstract

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a new second line medication in the management of hyperglycemia in type 2 diabetes. These drugs can be associated with the development of diabetic ketoacidosis (DKA) with normal or moderately increased blood glucose levels. This is a life threatening clinical condition termed euglycemic DKA, of which the diagnosis can be delayed due to the relative euglycemia. We report on two patients with type 2 diabetes who presented to the Emergency Department with malaise, nausea and vomiting. Both patients had been taking dapagliflozin for at least six months. A risk factor for the development of ketoacidosis, namely heavy alcohol consumption, was found in one of the patients. Arterial blood gas analysis showed severe metabolic acidosis with increased anion gap, positive serum and urine ketones and normal arterial lactate. The patients were treated in Internal Medicine with intravenous fluids, insulin, sodium bicarbonate and potassium. Dapagliflozin was stopped. Both patients recovered uneventfully. Even in the absence of significant hyperglycemia, accurate interpretation of arterial blood gas analysis and serum ketones should lead to correct diagnosis of euDKA.

Keywords

Citation

Antonio Burgio, Maurizio Alletto, Salvatore Amico, Umberto Castiglione, Giovanni Fulco, Concetta Groppuso and Gianfranco Gruttadauria (February 24, 2019). Euglycemic diabetic ketoacidosis in type 2 diabetes mellitus treated with SGLT2 inhibitors a report on two cases. Frenxiv. https://doi.org/10.31226/osf.io/sphax

Find this record

This record is deposited on the Open Science Framework and carries a persistent DOI. Use the links below to locate it in scholarly indexes.

Open research

Open research infrastructure

Frenxiv records connect to the wider scholarly record. These services support discovery, identifiers, preservation and open licensing.